
Octavio Ramilo MD
Professor, Pediatrics, Ohio State University College of Medicine
Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3300
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Octavio Ramilo, MD is a pediatric infectious disease specialist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee, Ohio, and Texas. He is a Professor at Ohio State University College of Medicine.
Education & Training
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 1990 - 1993
- Complutense University of MadridClass of 1981
Certifications & Licensure
- OH State Medical License 2009 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 1994 - 2024
- OK State Medical License 1993 - 2023
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 3 citationsNasal Mucosal Cytokines as Potential Biomarkers for Assessing Disease Severity and Class of Pathogen in Children With Community-Acquired Pneumonia.Rouba Sayegh, Li Tang, Ki Wook Yun, Zhaohui Xu, Sarah A Marzec
The Journal of Infectious Diseases. 2025-04-15 - 2 citationsClinical Features and Management Strategies in Children With Mycoplasma Pneumoniae.Tamara Garcia, Todd A Florin, Jan Leonard, Samir S Shah, Richard M Ruddy
Pediatric Emergency Care. 2025-04-01 - 1 citationsTranscriptomic Biomarkers Associated With Microbiological Etiology and Disease Severity in Childhood Pneumonia.Derek J Williams, Shruti Gautam, C Buddy Creech, Natalia Jimenez, Evan J Anderson
The Journal of Infectious Diseases. 2025-02-20
Press Mentions
- FDA Approves Merck’s ENFLONSIA to Prevent RSV in Infants During First SeasonJuly 2nd, 2025
- FDA Approves Clesrovimab to Prevent RSV in InfantsJune 20th, 2025
- HMN 2025: What Are the Toddler Immune Methods Reply in a Different Way to Extreme COVID-19May 17th, 2025
- Join now to see all
Grant Support
- Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and OutcomeUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
- Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and OutcomeUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
- Early life respiratory viral infections shape immune development trajectoriesST. JUDE CHILDREN'S RESEARCH HOSPITAL2022–2027
- Resubmission: Elucidating Pediatric Sepsis by Defining Comprehensive Signatures for Diagnosis and OutcomeUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
- SMILE: Sickle Cell Disease Microbiologic and Immunologic Links to Health EquityEMORY UNIVERSITY2023–2025